Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemary Young

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2008
Probiotics in the United StatesJon A Vanderhoof, Rosemary Young
Journal of Natural Products|April 9, 2025
Rhodospermals A-G: an Extension to the Chemical Diversity of Compounds Possessing a Unique Spiroketal with a Fused α,β-Unsaturated δ-Lactone Isolated from the Leaves of <i>Cryptocarya rhodosperma</i> (Lauraceae)Ritesh Raju, Matthew J Wallis, Jason Cullen, et al.
Women and Birth : Journal of the Australian College of Midwives|February 8, 2017
Barriers to a healthy lifestyle post gestational-diabetes: An Australian qualitative studyTehzeeb Zulfiqar, Fiona E Lithander, Cathy Banwell, et al.
Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|February 16, 2018
Barriers to a healthy lifestyle for three- to four-year-old children of Australian-born and overseas-born mothers with post-gestational diabetes: An Australian qualitative studyTehzeeb Zulfiqar, Christopher J Nolan, Cathy Banwell, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trialRosemary Young, Paul Mainwaring, Philip Clingan, et al.
British Journal of Cancer|February 12, 2016
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trialNiall C Tebbutt, Timothy J Price, Danielle A Ferraro, et al.
Journal of the National Cancer Institute|February 2, 2015
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trialDavid Goldstein, Robert Hassan El-Maraghi, Pascal Hammel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2008
Probiotics in the United StatesJon A Vanderhoof, Rosemary Young
Journal of Natural Products|April 9, 2025
Rhodospermals A-G: an Extension to the Chemical Diversity of Compounds Possessing a Unique Spiroketal with a Fused α,β-Unsaturated δ-Lactone Isolated from the Leaves of <i>Cryptocarya rhodosperma</i> (Lauraceae)Ritesh Raju, Matthew J Wallis, Jason Cullen, et al.
Women and Birth : Journal of the Australian College of Midwives|February 8, 2017
Barriers to a healthy lifestyle post gestational-diabetes: An Australian qualitative studyTehzeeb Zulfiqar, Fiona E Lithander, Cathy Banwell, et al.
Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|February 16, 2018
Barriers to a healthy lifestyle for three- to four-year-old children of Australian-born and overseas-born mothers with post-gestational diabetes: An Australian qualitative studyTehzeeb Zulfiqar, Christopher J Nolan, Cathy Banwell, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trialRosemary Young, Paul Mainwaring, Philip Clingan, et al.
British Journal of Cancer|February 12, 2016
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trialNiall C Tebbutt, Timothy J Price, Danielle A Ferraro, et al.
Journal of the National Cancer Institute|February 2, 2015
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trialDavid Goldstein, Robert Hassan El-Maraghi, Pascal Hammel, et al.
Pageof 1